Relationship Between Carfilzomib Dose and Efficacy Outcomes in Patients With Relapsed and/or Refractory Multiple Myeloma. Squifflet, P.; Michiels, S.; Siegel, D.; Vij, R.; Jagannath, S.; Saad, E. D.; Rajangam, K.; Ro, S. K.; Buyse, M.. Clin Lymphoma Myeloma Leuk. 2015; 680-6: p.680-6. doi:10.1016/j.clml.2015.09.005 10.1016/j.clml.2015.09.005. Epub 2015 Sep 25.Article
Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit. Habr, Bassem; Charpentier, Julien; Champigneulle, Benoît; Dechartres, Agnès; Daviaud, Fabrice; Geri, Guillaume; Cariou, Alain; Chiche, Jean-Daniel; Mira, Jean-Paul; Pène, Frédéric. Annals of Intensive Care. 2015; 5: . doi:10.1186/s13613-015-0088-2Article
Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies. Dandine-Roulland, Claire; Perdry, Hervé. European journal of human genetics: EJHG. 2015; 23: p.1357-1363. doi:10.1038/ejhg.2014.284Article
Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al. de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J.. Ann Oncol. 2015; 2196-7: p.2196-7. doi:10.1093/annonc/mdv301 10.1093/annonc/mdv301. Epub 2015 Jul 20.Article
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management]. Luporsi, E.; Bellocq, J. P.; Barrière, J.; Bonastre, J.; Chetritt, J.; Le Corroller, A. G.; de Cremoux, P.; Fina, F.; Gauchez, A. S.; Lamy, P. J.; Martin, P. M.; Mazouni, C.; Peyrat, J. P.; Romieu, G.; Verdoni, L.; Mazeau-Woynar, V.; Kassab-Chahmi, D.. Bull Cancer. 2015; 719-29: p.719-29Article
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. Tsao, M. S.; Marguet, S.; Le Teuff, G.; Lantuejoul, S.; Shepherd, F. A.; Seymour, L.; Kratzke, R.; Graziano, S. L.; Popper, H. H.; Rosell, R.; Douillard, J. Y.; Le-Chevalier, T.; Pignon, J. P.; Soria, J. C.; Brambilla, E. M.. J Clin Oncol. 2015; 3439-46: p.3439-46. doi:10.1200/JCO.2014.58.8335 10.1200/JCO.2014.58.8335. Epub 2015 Apr 27.Article
Impact of a printed decision aid on patients' intention to undergo prostate cancer screening: a multicentre, pragmatic randomised controlled trial in primary care. Tran, V. T.; Kisseleva-Romanova, E.; Rigal, L.; Falcoff, H.. Br J Gen Pract. 2015; e295-304: p.e295-304. doi:65/634/e295 [pii] 10.3399/bjgp15X684817Article
Obesity and carotid artery remodeling. Kozakova, M.; Palombo, C.; Morizzo, C.; Højlund, K.; Hatunic, M.; Balkau, B.; Nilsson, P. M.; Ferrannini, E.. Nutrition & Diabetes. 2015; 5: p.e177. doi:10.1038/nutd.2015.26Article
Positive Predictive Value of French Hospitalization Discharge Codes for Stroke and Transient Ischemic Attack. Giroud, Maurice; Hommel, Marc; Benzenine, Eric; Fauconnier, Jérôme; Béjot, Yannick; Quantin, Catherine; FRESCO Study. European Neurology. 2015; 74: p.92-99. doi:10.1159/000438859Article
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study. Østergaard, Søren D.; Mukherjee, Shubhabrata; Sharp, Stephen J.; Proitsi, Petroula; Lotta, Luca A.; Day, Felix; Perry, John R. B.; Boehme, Kevin L.; Walter, Stefan; Kauwe, John S.; Gibbons, Laura E.; Alzheimer’s Disease Genetics Consortium; GERAD1 Consortium; EPIC-InterAct Consortium; Larson, Eric B.; Powell, John F.; Langenberg, Claudia; Crane, Paul K.; Wareham, Nicholas J.; Scott, Robert A.. PLoS medicine. 2015; 12: p.e1001841; discussion e1001841. doi:10.1371/journal.pmed.1001841Article